Literature DB >> 31729048

Kinetic-pharmacodynamic model for drugs with non-linear elimination: Parameterisation matters.

Qing Xi Ooi1, Chihiro Hasegawa1, Stephen B Duffull1, Daniel F B Wright1.   

Abstract

Keywords:  KPD model; Kinetic-pharmacodynamic model; dose-response-time analysis; non-linear clearance; non-linear elimination

Mesh：

Substances：

Year:  2020        PMID： 31729048      PMCID： PMC7015753          DOI： 10.1111/bcp.14154

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

Review 1.  Modeling of dose-response-time data: four examples of estimating the turnover parameters and generating kinetic functions from response profiles.

Authors:  J Gabrielsson; W J Jusko; L Alari
Journal:  Biopharm Drug Dispos       Date:  2000-03       Impact factor: 1.627

2.  Modelling response time profiles in the absence of drug concentrations: definition and performance evaluation of the K-PD model.

Authors:  P Jacqmin; E Snoeck; E A van Schaick; R Gieschke; P Pillai; J-L Steimer; P Girard
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-10-19       Impact factor: 2.745

3.  Modelling the dose-response relationship: the fair share of pharmacokinetic and pharmacodynamic information.

Authors:  Mario González-Sales; Fahima Nekka; Mario Tanguay; Pierre-Olivier Tremblay; Jun Li
Journal:  Br J Clin Pharmacol       Date:  2017-02-14       Impact factor: 4.335

4.  Correction.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  2018-06-15       Impact factor: 4.335

5.  Dose-response-time data analysis involving nonlinear dynamics, feedback and delay.

Authors:  Johan Gabrielsson; Lambertus A Peletier
Journal:  Eur J Pharm Sci       Date:  2014-04-19       Impact factor: 4.384

6.  Quantitative determination of drug bioavailability and biokinetic behavior from pharmacological data for ophthalmic and oral administrations of a mydriatic drug.

Authors:  V F Smolen
Journal:  J Pharm Sci       Date:  1971-03       Impact factor: 3.534

7.  Kinetic-pharmacodynamic model for drugs with non-linear elimination: Parameterisation matters.

Authors:  Qing Xi Ooi; Chihiro Hasegawa; Stephen B Duffull; Daniel F B Wright
Journal:  Br J Clin Pharmacol       Date:  2020-01-10       Impact factor: 4.335
  7 in total
  2 in total

1.  Kinetic-pharmacodynamic model for drugs with non-linear elimination: Parameterisation matters.

Authors:  Qing Xi Ooi; Chihiro Hasegawa; Stephen B Duffull; Daniel F B Wright
Journal:  Br J Clin Pharmacol       Date:  2020-01-10       Impact factor: 4.335

2.  Phase I dose-escalation oncology trials with sequential multiple schedules.

Authors:  Burak Kürsad Günhan; Sebastian Weber; Abdelkader Seroutou; Tim Friede
Journal:  BMC Med Res Methodol       Date:  2021-04-14       Impact factor: 4.615
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.